Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Agilent Technologies (NY: A )

143.82 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
YLCHAT Triumphs on Nasdaq: A Digital Revolution in Financial Integration
Via GlobePRwire
Analyst Ratings For Agilent Technologies
Via Benzinga
AGILENT TECHNOLOGIES INC (NYSE:A) Exhibits Quality Stock Traits. Here's Why.
Is AGILENT TECHNOLOGIES INC (NYSE:A) a Strong Candidate for Quality Investing? 
Via Chartmill
Agilent to Host Analyst and Investor Day on Dec. 17, 2024
From Agilent Technologies Inc.
Via Business Wire
Here's How Much $100 Invested In Agilent Technologies 20 Years Ago Would Be Worth Today
Via Benzinga
Agilent Completes Acquisition of BIOVECTRA
From Agilent Technologies Inc.
Via Business Wire
Here's How Much $100 Invested In Agilent Technologies 20 Years Ago Would Be Worth Today
Via Benzinga
Peering Into Agilent Technologies's Recent Short Interest
Via Benzinga
Agilent Announces Cash Dividend of 23.6 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
From Agilent Technologies Inc.
Via Business Wire
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets. 
Via MarketBeat
$100 Invested In Agilent Technologies 20 Years Ago Would Be Worth This Much Today
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,500 Today
Via Benzinga
(A) - Analyzing Agilent Technologies's Short Interest
Via Benzinga
Critical Insights From Agilent Technologies Analyst Ratings: What You Need To Know
Via Benzinga
US Stocks Fall As Dollar, Treasury Yields Rise Ahead Of Fed's Jackson Hole; Oil Rebounds: What's Driving Markets Thursday?
Wall Street faced a downturn on Thursday as traders exercised caution ahead of Federal Reserve Chair Jerome Powell’s speech at the Jackson Hole Symposium on Friday. 
Via Benzinga
Topics Economy
Exposures Interest Rates
These Analysts Boost Their Forecasts On Agilent After Strong Earnings
Via Benzinga
Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off
Agilent Technologies reports Q3 results with revenue of $1.58B, surpassing street view. Q4 revenue forecasted at $1.641B-$1.691B and FY24 revenue revised to $6.45B-$6.5B. 
Via Benzinga
US Stocks Poised For Tepid Start Ahead Of Private Sector Activity Data And Jackson Hole Symposium: Analyst Says Market Is Focused On Nvidia Earnings And 'Waiting Is The Hardest Part'
Index futures trading point to a slightly positive start on Thursday, with some key Main Street data likely directing the market. Sentiment could remain guarded as traders look ahead to the 3-day... 
Via Benzinga
Topics Economy
Exposures Interest Rates
A Stock Earnings: Agilent Technologies Beats EPS, Beats Revenue for Q3 2024
A stock results show that Agilent Technologies beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 20 Years
Via Benzinga
Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Nasdaq, S&P 500 Futures Edge Up As Traders Look Ahead To FOMC Minutes: Strategist Flags 3 Trends That Could Help Stocks Withstand Volatility
U.S. stocks could claw back their losses, although nervousness is palpable as traders play the waiting game ahead of Federal Reserve Chair Jerome Powell’s Jackson Hole address on Friday. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
From Agilent Technologies Inc.
Via Business Wire
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024... 
Via Benzinga
Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology
From Agilent Technologies Inc.
Via Business Wire
Agilent to Acquire North American CDMO BIOVECTRA
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce Third-Quarter Fiscal Year 2024 Financial Results Aug. 21
From Agilent Technologies Inc.
Via Business Wire
History Says These Could Be 3 of the Best Healthcare Stocks to Own in the Second Half of 2024
These are solid stocks that have all generated 10-year returns in excess of 200%. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.